Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Kent W. Stanger sold 2,918 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $44.55, for a total transaction of $129,996.90. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Kent W. Stanger also recently made the following trade(s):

  • On Thursday, September 14th, Kent W. Stanger sold 670 shares of Merit Medical Systems stock. The shares were sold at an average price of $42.06, for a total transaction of $28,180.20.
  • On Monday, September 11th, Kent W. Stanger sold 1,930 shares of Merit Medical Systems stock. The shares were sold at an average price of $42.02, for a total transaction of $81,098.60.

Merit Medical Systems, Inc. (MMSI) traded down $0.25 during trading on Friday, hitting $43.20. 334,979 shares of the stock traded hands, compared to its average volume of 387,647. The company has a market capitalization of $2,140.00, a PE ratio of 34.69, a P/E/G ratio of 2.98 and a beta of 1.20. Merit Medical Systems, Inc. has a 52-week low of $24.23 and a 52-week high of $45.50. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The company had revenue of $179.30 million during the quarter, compared to analyst estimates of $181.28 million. During the same period in the previous year, the business earned $0.26 earnings per share. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. equities research analysts forecast that Merit Medical Systems, Inc. will post 1.27 EPS for the current year.

A number of large investors have recently made changes to their positions in the stock. Wolverine Trading LLC purchased a new position in Merit Medical Systems in the third quarter worth $226,000. Insight Capital Research & Management Inc. purchased a new position in Merit Medical Systems in the third quarter worth $1,258,000. Neuberger Berman Group LLC grew its position in Merit Medical Systems by 1,420.2% in the third quarter. Neuberger Berman Group LLC now owns 304,049 shares of the medical instruments supplier’s stock worth $12,876,000 after acquiring an additional 284,049 shares in the last quarter. California Public Employees Retirement System grew its position in Merit Medical Systems by 5.9% in the third quarter. California Public Employees Retirement System now owns 142,092 shares of the medical instruments supplier’s stock worth $6,018,000 after acquiring an additional 7,892 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in Merit Medical Systems in the third quarter worth $8,889,000. Institutional investors own 90.91% of the company’s stock.

Several research analysts have recently weighed in on MMSI shares. UBS cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a report on Monday, August 28th. Citigroup cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a report on Monday, August 28th. They noted that the move was a valuation call. Raymond James Financial reaffirmed an “outperform” rating and issued a $44.00 price target on shares of Merit Medical Systems in a report on Monday, August 28th. Canaccord Genuity reaffirmed a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a report on Wednesday, September 6th. Finally, Zacks Investment Research cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. One research analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. Merit Medical Systems has an average rating of “Buy” and a consensus price target of $43.77.

TRADEMARK VIOLATION WARNING: “Merit Medical Systems, Inc. (MMSI) Director Kent W. Stanger Sells 2,918 Shares” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/01/merit-medical-systems-inc-mmsi-director-kent-w-stanger-sells-2918-shares.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.